In contrast to prior reviews, this article synthesizes the findings across multiple studies to provide a comprehensive description of the regulators of BDNF trafficking in the regulated secretory pathway and links these mechanisms to major depressive disorder, schizophrenia, autism spectrum disorders, Huntington’s disease, and Alzheimer’s disease. Here, BDNF is linked to major depressive disorder.